Dr. Matteo Bellone obtained an M.D. degree (summa cum laude) and was Board Certified in Allergology and Clinical Immunology (summa cum laude) at the Università degli Studi di Milano. He had a 3-year post-doctoral training at the University of Minnesota, working in the field of autoimmunity with Dr. Bianca Conti-Fine for the last 25 years he has been working in the fields of cancer immunology and immunotherapy, in which is internationally well recognized as expert in mouse models of prostate cancer, melanoma, and more recently, myeloma (> 90 peer-reviewed publications; > 50 publications as first/last author; average impact factor: > 6).

He is Head of the Cellular Immunology Unit, and Deputy Director of the Network in Translational Research to Improve Prostate Cancer Treatment (NET-IMPACT) at IRCCS Ospedale San Raffaele, where he also practices as medical consultant in the field of Clinical Immunology. He is adjunct professor of Immunology at the Università Vita-Salute San Raffaele. He is Associate Editor at Frontiers in Immunology and Frontiers in Oncology, and member of several boards serving scientific journals and charities. He is Secretary and Treasurer of the Network Italiano per la BioTerapia dei Tumori (NIBIT) association, and member of the Società Italiana di Immunologia, Immunologia Clinica ed Allergologia (SIICA), and the American Association for Cancer Research (AACR).